[1]
2026. PATHOGENETIC CORRECTION OF MICROVASCULAR DYSFUNCTION WITH THE USE OF IMMUNOMODULATING THERAPY IN PATIENTS WITH RESISTANT ANGINA. INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION. 3, 4 (Jun. 2026), 165–166.